Clusterin as a blood biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease
With increasing global life expectancy, Alzheimer's disease will become an increasingly prevalent health problem. The development of biomarkers that predict risk for both Alzheimer's disease and mild cognitive impairment will be useful for early diagnosis of dementia. To date, no surrogate...
Saved in:
Main Authors: | Panachamnong,N., Methapatara,P., Sungkarat,S., Taneyhill,K., Intasai,N. |
---|---|
Format: | Article |
Published: |
Chiang Mai University
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84908378905&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Biomarkers of mild cognitive impairment and Alzheimer's disease
by: Tang, B.L., et al.
Published: (2011) -
Unplanned stopping strategy in individuals with mild cognitive impairment
by: Sirinun Boripuntakul, et al.
Published: (2018) -
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment
by: Chai, Yuek Ling, et al.
Published: (2021) -
Unplanned stopping strategy in individuals with mild cognitive impairment
by: Boripuntakul S., et al.
Published: (2017) -
Screening for mild cognitive impairment and early Alzheimer's disease
by: LI MINGLEI
Published: (2010)